Search by Drug Name or NDC
NDC 00990-7982-09 Ringers 33; 30; 860 mg/100mL; mg/100mL; mg/100mL Details
Ringers 33; 30; 860 mg/100mL; mg/100mL; mg/100mL
Ringers is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ICU Medical Inc.. The primary component is CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE.
Product Information
| NDC | 00990-7982 |
|---|---|
| Product ID | 0990-7982_5ced9253-c5e1-40d5-bf87-347e6470823b |
| Associated GPIs | 79992001302010 |
| GCN Sequence Number | 001427 |
| GCN Sequence Number Description | Ringer's solution IV SOLN INTRAVEN |
| HIC3 | C1W |
| HIC3 Description | ELECTROLYTE MAINTENANCE |
| GCN | 04220 |
| HICL Sequence Number | 000614 |
| HICL Sequence Number Description | RINGER'S SOLUTION |
| Brand/Generic | Generic |
| Proprietary Name | Ringers |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 33; 30; 860 |
| Active Ingredient Units | mg/100mL; mg/100mL; mg/100mL |
| Substance Name | CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
| Labeler Name | ICU Medical Inc. |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [ |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA018251 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00990-7982-09 (00990798209)
| NDC Package Code | 0990-7982-09 |
|---|---|
| Billing NDC | 00990798209 |
| Package | 12 POUCH in 1 CASE (0990-7982-09) / 1 BAG in 1 POUCH / 1000 mL in 1 BAG |
| Marketing Start Date | 2020-02-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |